In a study incorporating subjects from the Women’s Health Initiative exploring the premalignant mutational landscape of AML, all subjects with IDH1/2 mutations eventually developed AML, highlighting the potential benefit of early intervention [58]. The gene discussed is IDH1; the disease is acute myeloid leukemia.